---
title: "Ecovyst (ECVT) Receives a Buy from Freedom Capital Markets"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291141751.md"
description: "Ecovyst received a Buy rating and a $15.00 price target from Freedom Capital Markets analyst today.End of Quarter Sale - 70% Off Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Ecovyst with a $15.38 average price target."
datetime: "2026-06-29T11:55:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291141751.md)
  - [en](https://longbridge.com/en/news/291141751.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291141751.md)
---

# Ecovyst (ECVT) Receives a Buy from Freedom Capital Markets

Ecovyst received a Buy rating and a $15.00 price target from Freedom Capital Markets analyst today.

### End of Quarter Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Ecovyst with a $15.38 average price target.

### Related Stocks

- [ECVT.US](https://longbridge.com/en/quote/ECVT.US.md)

## Related News & Research

- [Ecovyst Inc. (NYSE:ECVT) Given Average Recommendation of "Moderate Buy" by Brokerages](https://longbridge.com/en/news/285058461.md)
- [FMC Corp’s Forward-Looking Statements: Why Investors Face Hidden Risks From Unupdated Projections](https://longbridge.com/en/news/294470836.md)
- [CCOI Stock Drop: Cogent Wavelength Business Issues Lead to 56% Stock Drop and Securities Fraud Class Action for Investors](https://longbridge.com/en/news/294807654.md)
- [Rein Therapeutics publishes first-in-human LTI-03 idiopathic pulmonary fibrosis data in Nature Communications](https://longbridge.com/en/news/294821300.md)
- [Thompson Davis Reaffirms Their Buy Rating on EMCOR Group (EME)](https://longbridge.com/en/news/294416611.md)